Meeting
2018 ASCO Quality Care Symposium
Nationwide utilization and costs of targeted anti-cancer drugs for elderly patients with solid tumors in the United States, 2004-2015.
Authors
Lauren E Wilson
Duke University School of Medicine, Durham, NC
Lauren E Wilson, Melissa Greiner, Ivy Altomare, Jason Rotter, Michaela Ann Dinan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Big Data Studies; Projects Relating to Equity, Value, and Policy
Track
Projects Relating to Equity, Value and Policy,Big Data Studies
Sub Track
Studies Using Existing Registries or Databases cd
Citation
J Clin Oncol 36, 2018 (suppl 30; abstr 23)
DOI
10.1200/JCO.2018.36.30_suppl.23
Abstract #
23
Poster Bd #
D9
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Systemic anti-cancer therapy and cost at end of life: A SEER Medicare analysis.
First Author: Kerin B. Adelson
Poster
2023 ASCO Quality Care Symposium
Impact of the COVID-19 pandemic on administration of systemic therapy in the Medicare population.
First Author: Peter Kardel
Poster
2023 ASCO Annual Meeting
Association of measures of socioeconomic deprivation with healthcare utilization in elderly patients enrolled in SWOG cancer clinical trials.
First Author: Dawn L. Hershman
Poster
2023 ASCO Annual Meeting
TROPION-PanTumor03: Phase 2, multicenter study of datopotamab deruxtecan (Dato-DXd) as monotherapy and in combination with anticancer agents in patients (pts) with advanced/metastatic solid tumors.
First Author: Yelena Y. Janjigian